2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Diabetes Mellitus, Type 1 in 2 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hyun, E | 1 |
Ramachandran, R | 1 |
Cenac, N | 1 |
Houle, S | 1 |
Rousset, P | 1 |
Saxena, A | 1 |
Liblau, RS | 1 |
Hollenberg, MD | 1 |
Vergnolle, N | 1 |
Lin, HY | 1 |
Tsai, CC | 1 |
Chen, LL | 1 |
Chiou, SH | 1 |
Wang, YJ | 1 |
Hung, SC | 1 |
2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Diabetes Mellitus, Type 1
Article | Year |
---|---|
Insulin modulates protease-activated receptor 2 signaling: implications for the innate immune response.
Topics: Animals; Calcium; Cell Line; Cells, Cultured; Chromones; Diabetes Mellitus, Type 1; Endothelial Cell | 2010 |
Fibronectin and laminin promote differentiation of human mesenchymal stem cells into insulin producing cells through activating Akt and ERK.
Topics: Blotting, Western; Cell Differentiation; Cell Line; Cell- and Tissue-Based Therapy; Chromones; Diabe | 2010 |